Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production
- PMID: 6416511
- PMCID: PMC1549785
- DOI: 10.1136/bmj.287.6405.1580
Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production
Abstract
Semisynthetic human insulin and highly purified porcine insulin were compared in a double blind crossover study in 21 diabetic children. Glycosylated haemoglobin values at the end of four month treatment periods were higher after treatment with human insulin than after treatment with porcine insulin (mean 15.7% (SD 2.3%) v 14.2% (2.3%); p less than 0.01). Higher fasting blood glucose concentrations occurred during treatment with human insulin than with porcine insulin (mean 12.0 (SD 2.1) v 11.0 (2.4) mmol/1; mean 216 (SD 38) v 198 (43) mg/100 ml; p less than 0.05), but there were no significant differences at other time points during the day. The incidence of hypoglycaemia was similar for both treatment groups. Concentrations of antibody reactive with porcine and human insulins were similar for the two treatment groups, although greater fluctuation was observed in the amount of antibody reactive with human insulin. Semisynthetic human insulin is safe and effective in diabetic children, although further work is needed to devise regimens which achieve optimal blood glucose control.
Similar articles
-
Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.Diabete Metab. 1989 May-Jun;15(3):107-10. Diabete Metab. 1989. PMID: 2668052
-
Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.Diabete Metab. 1988 Jul-Aug;14(4):415-21. Diabete Metab. 1988. PMID: 3066649
-
Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.Aust N Z J Med. 1986 Apr;16(2):206-10. doi: 10.1111/j.1445-5994.1986.tb01149.x. Aust N Z J Med. 1986. PMID: 3530226 Clinical Trial.
-
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.Cochrane Database Syst Rev. 2021 Mar 4;3(3):CD013498. doi: 10.1002/14651858.CD013498.pub2. Cochrane Database Syst Rev. 2021. PMID: 33662147 Free PMC article.
-
Insulin during pregnancy, labour and delivery.Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21186142 Review.
Cited by
-
Human insulin and unawareness of hypoglycaemia: need for a large randomised trial.BMJ. 1992 Aug 8;305(6849):351-5. doi: 10.1136/bmj.305.6849.351. BMJ. 1992. PMID: 1392889 Free PMC article. No abstract available.
-
Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.Acta Diabetol Lat. 1986 Apr-Jun;23(2):101-6. doi: 10.1007/BF02624669. Acta Diabetol Lat. 1986. PMID: 3529776
-
Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice.DNA Cell Biol. 2018 Aug;37(8):680-690. doi: 10.1089/dna.2017.3937. Epub 2018 Jun 21. DNA Cell Biol. 2018. PMID: 29927618 Free PMC article.
-
Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.Diabetologia. 1987 Dec;30(12):912-5. doi: 10.1007/BF00295873. Diabetologia. 1987. PMID: 3325323
-
Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases.Cell Transplant. 2021 Jan-Dec;30:9636897211011995. doi: 10.1177/09636897211011995. Cell Transplant. 2021. PMID: 33975464 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical